跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
THIOTEPA FOR INJECTION USP
Authorized
STANDARD
THIOTEPA FOR INJECTION USP
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5875246d735f2ff5
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
5875246d735f2ff5
Drug Approval Canada Name
THIOTEPA FOR INJECTION USP
Product Name
THIOTEPA FOR INJECTION USP
Status
Marketed
Status Date
2023-02-15
Original Market Date
2023-02-15
Din
02526417
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01AC01 THIOTEPA
Atc Name
l 01 ac 01
Aig Number
0107649001
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
THIOTEPA
15 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5875246d735f2ff5
Type
Standard
Back to Health Canada Approvals
THIOTEPA FOR INJECTION USP - Health Canada Drug Approval Details